NCT01762280View on ClinicalTrials.gov

A Phase I Study of Famitinib Malate in Patients With Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

July 31, 2012

Conditions
Advanced Solid Tumor
Interventions
DRUG

Famitinib Malate Capsule

Trial Locations (1)

Unknown

Cancer Institute and Hospital Chinese Academy of Medical Sciences, Beijing

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences

OTHER

collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT01762280 - A Phase I Study of Famitinib Malate in Patients With Solid Tumor | Biotech Hunter | Biotech Hunter